Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

FP5

NASAL VACCINATION

Project ID: QLK2-CT-2002-71587
Financé au titre de

Enhancement of intranasal vaccination-improved immune protection and cost-effictiveness by combining optimised mucosal adjuvant and nasal delivery system (NASAL VACCINATION)

De 2002-12-01 à 2005-08-31

Détails concernant le projet

Coût total:

EUR 1 679 650

Contribution de l'UE:

EUR 839 825

Coordonné à/au(x)/en:

Sweden

Régime de financement:

CRS - Cooperative research contracts

Coordinateur

EUROCINE AB
Sweden
Karolinska Institute Science Park, Foqdevreten 2
171 77 STOCKHOLM
Sweden
See on map
Contact administratif: N/A

Participants

DIABACT AB
Sweden
Kungsgatan, 109
751 05 UPPSALA
Sweden
See on map
Contact administratif: N/A
FEM DESIGN AS
Norway
Sagveien, 21
0459 OSLO
Norway
See on map
Contact administratif: N/A
FOUNDATION FOR TECHNICAL AND INDUSTRIAL RESEARCH AT THE NORWEGIAN INSTITUTE OF TECHNOLOGY
Norway
1 D,Strindveien 4
7465 TRONDHEIM
Norway
See on map
Contact administratif: N/A
OPTINOSE AS
Norway
Lokka Skogen 18c
0773 OSLO
Norway
See on map
Contact administratif: N/A
SIUMSURGERY AS
Norway
Sognsveien, 75 B
0865 OSLO
Norway
See on map
Contact administratif: N/A
SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL
Sweden
2,Nobels vaag 18
171 82 SOLNA
Sweden
See on map
Contact administratif: N/A